Clinical Trial Update: Sirolimus Treatment for Refractory PRCA [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on sirolimus for refractory Pure Red Cell Aplasia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pure Red Cell Aplasia

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Bing Han | Conditions: Pure Red Cell Aplasia | Phase 4 | Status: COMPLETED